PS

Patrick Soon-Shiong

NI Nant Holdings Ip: 230 patents #1 of 93Top 2%
AB Abraxis Bioscience: 45 patents #2 of 28Top 8%
NA Nantomics: 25 patents #3 of 38Top 8%
NA Nantcell: 24 patents #1 of 29Top 4%
IM Immunitybio: 23 patents #1 of 38Top 3%
NA Nantbio: 17 patents #2 of 51Top 4%
NA Nanthealth: 16 patents #1 of 22Top 5%
VP Vivorx Pharmaceuticals: 15 patents #1 of 16Top 7%
VI Vivorx: 14 patents #1 of 11Top 10%
CM Calcean Minerals And Materials: 9 patents #1 of 4Top 25%
NA Nantmobility: 8 patents #3 of 6Top 50%
AB American Bioscience: 7 patents #1 of 18Top 6%
NA Nantstudios: 6 patents #2 of 12Top 20%
NA Nantworks: 5 patents #1 of 9Top 15%
NA Nantkwest: 4 patents #4 of 11Top 40%
NA Nantbioscience: 4 patents #2 of 18Top 15%
FG Five3 Genomics: 4 patents #4 of 6Top 70%
AB Altor Bioscience: 2 patents #16 of 37Top 45%
TE Tensorcom: 1 patents #17 of 20Top 85%
NA Nanocav: 1 patents #7 of 10Top 70%
📍 Los Angeles, CA: #1 of 12,377 inventorsTop 1%
🗺 California: #119 of 386,348 inventorsTop 1%
Overall (All Time): #528 of 4,157,543Top 1%
432
Patents All Time

Issued Patents All Time

Showing 1–25 of 432 patents

Patent #TitleCo-InventorsDate
12430463 Token-based digital private data exchange systems, methods, and apparatus Nicholas J. Witchey 2025-09-30
12427152 HDAC inhibitors for use with NK cell based therapies James N. WOODY 2025-09-30
12427184 Treatment of immunosuppressed subjects 2025-09-30
12419813 Oolitic aragonite beads and methods therefor Anthony Myers, Alyson Myers, Harold Meherg 2025-09-23
12419336 Beverage compositions including calcium supplied from aragonite and methods of making the same 2025-09-23
12417671 Avatar-based sports betting 2025-09-16
12410096 Hydrophobic concrete and asphalt 2025-09-09
12412639 Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples Kevin B. Givechian, Kamil Wnuk, Chad Garner, Stephen Charles Benz, Hermes J. Garban +2 more 2025-09-09
D1091712 Personal transport vehicle Thomas Wittenschlaeger, Nathan H. Allen 2025-09-02
12403178 Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity) Hans G. Klingemann, Laurent H. Boissel, Himani Chinnapen, Abhijit Dandapat 2025-09-02
12401646 Enhanced access to media, systems and methods Andrew Konstantaras, John Wiacek, Nicholas J. Witchey 2025-08-26
12400745 Healthcare object recognition, systems and methods John Zachary Sanborn, Stephen Charles Benz, Charles Joseph Vaske 2025-08-26
12397019 Mesenchymal stem cell derived exosomes and methods Francesco Curcio, Kayvan Niazi 2025-08-26
12394164 Interaction analysis systems and methods 2025-08-19
12393564 Location indexed blockchains, systems and method Nicholas J. Witchey, John Wiacek, Jake Fyfe 2025-08-19
12386497 Shared real-time content editing activated by an image 2025-08-12
12385903 RP182 compositions and methods Kayvan Niazi 2025-08-12
12378300 Elimination of CD19-positive lymphoid malignancies by CD19-car expressing NK cells Hans G. Klingemann, Laurent H. Boissel 2025-08-05
12377365 Methods and systems for separating metals 2025-08-05
12381993 Distributed command execution in multi-location studio environments Gary Marshall, Keaton Heinrichs, John Wiacek, Nicholas J. Witchey 2025-08-05
12373783 Virtual planogram management systems and methods 2025-07-29
12369052 Multi-wigig channel multiplexor Vincent Dang 2025-07-22
12357046 Smart article visual communication based on facial movement Nicholas J. Witchey 2025-07-15
12354709 Systems, methods, and compositions for viral-associated tumors John Zachary Sanborn, Charles Joseph Vaske, Stephen Charles Benz, Shahrooz Rabizadeh, Nicole Hensley 2025-07-08
12350316 IL7-IL 15 TxM compositions and methods 2025-07-08